| SPEAKERS |
 | Jean Pierre Altier PhD, Former Vice President of Pricing & Reimbursement, PFIZER and Independent Consultant, ALTIER CONSULTING |  | Dr. Karthik Anantharaman Head-Medical Affairs, ABBOTT INDIA LTD |  |
Elizabeth Bewley President & CEO, PARIO HEALTH INSTITUTE |
 | Steve Boccuzzi Vice President, Health Technology Innovation & Research, MEDCO HEALTH INSTITUTE |  | Joshua Cohen Senior Research Fellow, TUFTS CENTER FOR THE STUDY OF DRUG DEVELOPMENT |  | Carol Gaich
HTA, Research Scientist ELI LILLY & CO. |
 | Mark Jewell, PhD
President, EPI-Q |  | Robert Kritzler
Deputy Chief Medical Officer, JOHN HOPKINS HEALTHCARE LLC |  |
Ken LaPensee Director, Health Economics, FOREST LABORATORIES INC |
 |
Catherine Melfi PhD, Senior Directors, Global Health Outcomes, ELI LILLY & CO |  | Terri Moore Pharmacy Reviewer, (URAC) |  | Robert Nauman Principal, BIOPHARMA ADVISORS |
 |
Steven Richardson, MD MS, Former National Medical Director, GLAXOSMITHKLINE |  |
Dexter Shurney MD, Medical Director, Employee Health and Care Plan, VANDERBILT UNIVERSITY AND MEDICAL CENTER |  | Susan W. Sharpless Director, Payer New Product Development, GLAXOSMITHKLINE |
 | Anthony Wisniewski
Senior Vice President, Strategic Developments, (URAC) |  | Randy Vogenberg, Executive Director, Biologic Finance & Access Council Program, JEFFERSON SCHOOL OF PUBLIC HEALTH |  | Raymond J. Zastrow, MD, FAAFP, President, QUADMED LLC |